A parallel investigation of hepatic sections stained with anti-Nrf2 antibodies revealed a reduction in the immunostaining in the sections from the HCC group, which was reversed by treatment with CAY10500 (Figure 4). This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.